Anti-Interleukin-17 Monoclonal Antibody Ixekizumab in Psoriasis REPLY

被引：0
|
作者：
Papp, Kim A. [1 ]
机构：
[1] Prob Med Res, Waterloo, ON, Canada
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2012年 / 367卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：275 / 275
页数：1
相关论文
共 50 条
  • [21] Clinical Response To Brodalumab, An Anti-Interleukin-17 Receptor Antibody, In Subjects With Psoriatic Arthritis
    Genovese, Mark C.
    Mease, Philip J.
    Greenwald, Maria W.
    Ritchlin, Christopher T.
    Beaulieu, Andre
    Deodhar, Atul
    Newmark, Richard
    Feng, JingYuan
    Erondu, Ngozi
    Nirula, Ajay
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S347 - S348
  • [22] Ixekizumab: an anti-IL-17A monoclonal antibody for the treatment of psoriatic arthritis
    Toussirot, Eric
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2018, 18 (01) : 101 - 107
  • [23] Brodalumab and ixekizumab, anti-interleukin-17-receptor antibodies for psoriasis: a critical appraisal
    Spuls, Ph. I.
    Hooft, L.
    BRITISH JOURNAL OF DERMATOLOGY, 2012, 167 (04) : 710 - 713
  • [24] Targeted anti-interleukin-17 therapy for linear porokeratosis
    Li, Donglin
    Technau-Hafsi, Kristin
    Giehl, Katrin
    Hoeger, Peter H.
    Has, Cristina
    BRITISH JOURNAL OF DERMATOLOGY, 2023, 189 (05) : 630 - +
  • [25] Brodalumab, an Anti-Interleukin-17-Receptor Antibody for Psoriasis
    Papp, Kim A.
    Leonardi, Craig
    Menter, Alan
    Ortonne, Jean-Paul
    Krueger, James G.
    Kricorian, Gregory
    Aras, Girish
    Li, Juan
    Russell, Chris B.
    Thompson, Elizabeth H. Z.
    Baumgartner, Scott
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (13): : 1181 - 1189
  • [26] Isothiazolinones in paint as a cause of airborne contact dermatitis in a patient with psoriasis receiving anti-interleukin-17 therapy
    Martinez-Mera, Constanza
    Gonzalez, Maria A.
    Hospital, Mercedes
    Turrion-Merino, Lucia
    CONTACT DERMATITIS, 2019, 80 (05) : 328 - +
  • [27] Anti-interleukin-17 and anti-interleukin-23 biologic drugs for genital psoriasis: a single-center retrospective comparative study
    Cortese, Andrea
    Gargiulo, Luigi
    Ibba, Luciano
    Fiorillo, Giovanni
    Toso, Francesco
    Vignoli, Carlo Alberto
    Narcisi, Alessandra
    Costanzo, Antonio
    Valenti, Mario
    DERMATOLOGY REPORTS, 2023, 15 (03)
  • [28] AMG 827, an anti-interleukin-17 receptor antibody, improves psoriasis symptoms: Results from a randomized, controlled, phase II study
    Gordon, Kenneth B.
    Kimball, Alexa
    Chau, Dina
    Kricorian, Gregory
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2012, 66 (04) : AB184 - AB184
  • [29] Brodalumab, an anti-interleukin-17 receptor A monoclonal antibody, in axial spondyloarthritis: 68-week results from a phase 3 study
    Kim, Tae-Hwan
    Kishimoto, Mitsumasa
    Wei, James Cheng-Chung
    Jeong, Haeyoun
    Nozaki, Akiyo
    Kobayashi, Shigeto
    RHEUMATOLOGY, 2023, 62 (05) : 1851 - 1859
  • [30] Decreased expression of IL-17 pathway genes in blood in patients with plaque psoriasis treated with the anti-IL-17A monoclonal antibody, ixekizumab
    Krueger, J. G.
    Dow, E. R.
    Nantz, E.
    Komocsar, W. J.
    Banerjee, P.
    Leonardi, C.
    Cameron, G. S.
    Banerjee, S.
    Hoffman, R. W.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2013, 133 : S18 - S18
12345